FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318067759> ?p ?o ?g. }

• W4318067759 abstract "Background Degradation of the endothelial protective glycocalyx layer during COVID-19 infection leads to shedding of major glycocalyx components. These circulating proteins and their degradation products may feedback on immune and endothelial cells and activate molecular signaling cascades in COVID-19 associated microvascular injury. To test this hypothesis, we measured plasma glycocalyx components in patients with SARS-CoV-2 infection of variable disease severity and identified molecular signaling networks activated by glycocalyx components in immune and endothelial cells. Methods We studied patients with RT-PCR confirmed COVID-19 pneumonia, patients with COVID-19 Acute Respiratory Distress Syndrome (ARDS) and healthy controls (wildtype, n=20 in each group) and measured syndecan-1, heparan sulfate and hyaluronic acid. The in-silico construction of signaling networks was based on RNA sequencing (RNAseq) of mRNA transcripts derived from blood cells and of miRNAs isolated from extracellular vesicles from the identical cohort. Differentially regulated RNAs between groups were identified by gene expression analysis. Both RNAseq data sets were used for network construction of circulating glycosaminoglycans focusing on immune and endothelial cells. Results Plasma concentrations of glycocalyx components were highest in COVID-19 ARDS. Hyaluronic acid plasma levels in patients admitted with COVID-19 pneumonia who later developed ARDS during hospital treatment (n=8) were significantly higher at hospital admission than in patients with an early recovery. RNAseq identified hyaluronic acid as an upregulator of TLR4 in pneumonia and ARDS. In COVID-19 ARDS, syndecan-1 increased IL-6, which was significantly higher than in pneumonia. In ARDS, hyaluronic acid activated NRP1, a co-receptor of activated VEGFA, which is associated with pulmonary vascular hyperpermeability and interacted with VCAN (upregulated), a proteoglycan important for chemokine communication. Conclusions Circulating glycocalyx components in COVID-19 have distinct biologic feedback effects on immune and endothelial cells and result in upregulation of key regulatory transcripts leading to further immune activation and more severe systemic inflammation. These consequences are most pronounced during the early hospital phase of COVID-19 before pulmonary failure develops. Elevated levels of circulating glycocalyx components may early identify patients at risk for microvascular injury and ARDS. The timely inhibition of glycocalyx degradation could provide a novel therapeutic approach to prevent the development of ARDS in COVID-19." @default.
• W4318067759 created "2023-01-26" @default.
• W4318067759 creator A5001654580 @default.
• W4318067759 creator A5013277891 @default.
• W4318067759 creator A5026414029 @default.
• W4318067759 creator A5032440972 @default.
• W4318067759 creator A5032653169 @default.
• W4318067759 creator A5033750097 @default.
• W4318067759 creator A5039476035 @default.
• W4318067759 creator A5065180441 @default.
• W4318067759 creator A5081359784 @default.
• W4318067759 creator A5090420092 @default.
• W4318067759 date "2023-01-26" @default.
• W4318067759 modified "2023-10-17" @default.
• W4318067759 title "Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19" @default.
• W4318067759 cites W1803784511 @default.
• W4318067759 cites W1985367738 @default.
• W4318067759 cites W1988186967 @default.
• W4318067759 cites W1988469595 @default.
• W4318067759 cites W2002330167 @default.
• W4318067759 cites W2004388967 @default.
• W4318067759 cites W2022064271 @default.
• W4318067759 cites W2063645267 @default.
• W4318067759 cites W2085665189 @default.
• W4318067759 cites W2102361557 @default.
• W4318067759 cites W2103398208 @default.
• W4318067759 cites W2113769407 @default.
• W4318067759 cites W2114568695 @default.
• W4318067759 cites W2120211786 @default.
• W4318067759 cites W2121725913 @default.
• W4318067759 cites W2122306511 @default.
• W4318067759 cites W2151485285 @default.
• W4318067759 cites W2155713473 @default.
• W4318067759 cites W2162143298 @default.
• W4318067759 cites W2163164437 @default.
• W4318067759 cites W2169455670 @default.
• W4318067759 cites W2193420313 @default.
• W4318067759 cites W2231907166 @default.
• W4318067759 cites W2620241325 @default.
• W4318067759 cites W2750610314 @default.
• W4318067759 cites W2805547508 @default.
• W4318067759 cites W2889806779 @default.
• W4318067759 cites W2976762162 @default.
• W4318067759 cites W3005104290 @default.
• W4318067759 cites W3008090866 @default.
• W4318067759 cites W3011508296 @default.
• W4318067759 cites W3013176450 @default.
• W4318067759 cites W3017125154 @default.
• W4318067759 cites W3023873927 @default.
• W4318067759 cites W3033997257 @default.
• W4318067759 cites W3080517202 @default.
• W4318067759 cites W3081159048 @default.
• W4318067759 cites W3084749441 @default.
• W4318067759 cites W3085046828 @default.
• W4318067759 cites W3092332314 @default.
• W4318067759 cites W3101792546 @default.
• W4318067759 cites W3112902030 @default.
• W4318067759 cites W3140915421 @default.
• W4318067759 cites W3153293222 @default.
• W4318067759 cites W3157103823 @default.
• W4318067759 cites W3158473060 @default.
• W4318067759 cites W3164721049 @default.
• W4318067759 cites W3184859363 @default.
• W4318067759 cites W3186093480 @default.
• W4318067759 cites W3198100741 @default.
• W4318067759 cites W3198105481 @default.
• W4318067759 cites W3201417446 @default.
• W4318067759 cites W3206317147 @default.
• W4318067759 cites W4200120351 @default.
• W4318067759 cites W4200289318 @default.
• W4318067759 cites W4206614061 @default.
• W4318067759 cites W4210322378 @default.
• W4318067759 cites W4221022908 @default.
• W4318067759 cites W4224237381 @default.
• W4318067759 cites W4281487617 @default.
• W4318067759 cites W4283215194 @default.
• W4318067759 cites W4295067041 @default.
• W4318067759 cites W4306399086 @default.
• W4318067759 cites W4313310025 @default.
• W4318067759 doi "https://doi.org/10.3389/fimmu.2023.1129766" @default.
• W4318067759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36776845" @default.
• W4318067759 hasPublicationYear "2023" @default.
• W4318067759 type Work @default.
• W4318067759 citedByCount "3" @default.
• W4318067759 countsByYear W43180677592023 @default.
• W4318067759 crossrefType "journal-article" @default.
• W4318067759 hasAuthorship W4318067759A5001654580 @default.
• W4318067759 hasAuthorship W4318067759A5013277891 @default.
• W4318067759 hasAuthorship W4318067759A5026414029 @default.
• W4318067759 hasAuthorship W4318067759A5032440972 @default.
• W4318067759 hasAuthorship W4318067759A5032653169 @default.
• W4318067759 hasAuthorship W4318067759A5033750097 @default.
• W4318067759 hasAuthorship W4318067759A5039476035 @default.
• W4318067759 hasAuthorship W4318067759A5065180441 @default.
• W4318067759 hasAuthorship W4318067759A5081359784 @default.
• W4318067759 hasAuthorship W4318067759A5090420092 @default.
• W4318067759 hasBestOaLocation W43180677591 @default.
• W4318067759 hasConcept C104317684 @default.
• W4318067759 hasConcept C105702510 @default.
• W4318067759 hasConcept C126322002 @default.

• next